Desloratadine set for OTC switch across Europe

19 October 2020 - Deborah Wilkes


Teva’s Desloratadine ratiopharm is set to become the sixth medicine to gain non-prescription status through the European Union’s centralised authorisation procedure.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: